According to regulatory filings, AstraZeneca Plc (LON: AZN) Chief Executive Pascal Soriot purchased 60,000 ordinary shares on September 14 at a price of £121.02 per share.
The transaction was disclosed to the market by AstraZeneca on September 18.
According to regulatory filings, AstraZeneca Plc (LON: AZN) Chief Executive Pascal Soriot purchased 60,000 ordinary shares on September 14 at a price of £121.02 per share.
The transaction was disclosed to the market by AstraZeneca on September 18.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.